- Email: [email protected]
2016 Acta Biomaterialia Gold Medal Award
Available online at www.sciencedirect.com
ScienceDirect Scripta Materialia 105 (2015) 1 www.elsevier.com/locate/scriptamat
2016 Acta Biomaterialia Gold Medal Award
Klaas de Groot has been awarded the highly acclaimed international 2016 Acta Biomaterialia Gold Medal Award. The award recognizes excellence and leadership in biomaterials, including basic science and translation to practice. Dr. de Groot, born in 1940, is – since 2008 - Emeritus Professor at the Tissue Engineering Group at Twente University, The Netherlands. Currently, he is still active in science as a scientific advisor at the Amsterdam School of Dentistry (ACTA), Department of Oral Implantology. He studied physical chemistry at the University of Groningen, the Netherlands, where he received his B.Sc. in 1961 and his M.Sc. in 1965. Thereafter he received a fellowship to spend two years as a post-grad at the University of North Carolina, at Chapel Hill, USA. He then returned to Groningen to obtain his Ph.D. in 1968. After some additional years as a post-grad at Dutch universities, he was appointed as Associate Professor of Dental Biomaterials at the Free University of Amsterdam, followed by a full professorship in 1980. In 1988 he took a part-time professorship at Leiden University, where he supervised the research group Medical Implants at that university’s School of Medicine, combining this part-time position with entrepreneurship. In 2002 he moved from Leiden to Twente University, where he retired in 2008 after having served as Honorary President of the 2008 Biomaterials World Conference in Amsterdam. After his
http://dx.doi.org/10.1016/j.scriptamat.2015.04.025
retirement he completed an M.A. in Philosophy of Science at Leiden University (2010). In the year 1972, he was visiting scientist at the UCLA Bone Research Laboratory of Professor Marshall R. Urist, who taught him the relevance of Bone Morphogenetic Proteins (BMPs) in bone research, and more particular, in including growth factors in bone biomaterials. In summer 1977 he was appointed as visiting professor at the University of Utah. In the 1980’s he started to cooperate with Chinese universities, which led to honorary appointments at several Chinese universities, among them the Beijing University and the University of Sichuan. Many Chinese students then received fellowships at the Amsterdam Free University, Leiden University, and Twente University. In 1994, the Chinese government awarded him with the Friendship Award, as an appreciation for his help to introduce biomaterials science into China and its universities. Under his supervision, about 50 students received their Ph.D. degrees, about half of them Dutch, and the other half from other European and Asian countries. He published about 350 scientific papers and holds several patents. His past scientific papers are still highly cited, as evidenced by his current (2015) Research Gate score of 45. His research concerned mainly implants to replace bone, bone joints, and teeth. Engineering technologies such as sintering and plasma spraying of calcium phosphate ceramics, introducing room temperature technologies to introduce BMPs and other drugs, including but not limited to antibiotics, into and onto bone implants, were designed and improved. He received many awards besides the already mentioned Chinese Friendship Award. To mention a few: the George Winter Award, the Clemson Award, Sir John Charnley Award, Honorary Member of the Dutch Society for Biomaterials. He was member, and elected as Fellow, of various professional societies such as The European Society for Biomaterials (ESB) and the American Society of Biomaterials, and was co-founder of the ESB. He (co-) founded a number of biomedical companies, such as CAM Bioceramics, which is a world leader in plasma sprayed calcium phosphate coatings and calcium phosphate particles repair and augmentation of skeletal implants; IsoTis as innovator in tissue engineering (Nasdaq listed for some time until it was incorporated into a US company); and Beijing Amsterdam Biomaterials (Beijing) which was set up to produce simple dental materials for the Chinese people (later sold to an internationally operating German dental company); and several others.
ScienceDirect Scripta Materialia 105 (2015) 1 www.elsevier.com/locate/scriptamat
2016 Acta Biomaterialia Gold Medal Award
Klaas de Groot has been awarded the highly acclaimed international 2016 Acta Biomaterialia Gold Medal Award. The award recognizes excellence and leadership in biomaterials, including basic science and translation to practice. Dr. de Groot, born in 1940, is – since 2008 - Emeritus Professor at the Tissue Engineering Group at Twente University, The Netherlands. Currently, he is still active in science as a scientific advisor at the Amsterdam School of Dentistry (ACTA), Department of Oral Implantology. He studied physical chemistry at the University of Groningen, the Netherlands, where he received his B.Sc. in 1961 and his M.Sc. in 1965. Thereafter he received a fellowship to spend two years as a post-grad at the University of North Carolina, at Chapel Hill, USA. He then returned to Groningen to obtain his Ph.D. in 1968. After some additional years as a post-grad at Dutch universities, he was appointed as Associate Professor of Dental Biomaterials at the Free University of Amsterdam, followed by a full professorship in 1980. In 1988 he took a part-time professorship at Leiden University, where he supervised the research group Medical Implants at that university’s School of Medicine, combining this part-time position with entrepreneurship. In 2002 he moved from Leiden to Twente University, where he retired in 2008 after having served as Honorary President of the 2008 Biomaterials World Conference in Amsterdam. After his
http://dx.doi.org/10.1016/j.scriptamat.2015.04.025
retirement he completed an M.A. in Philosophy of Science at Leiden University (2010). In the year 1972, he was visiting scientist at the UCLA Bone Research Laboratory of Professor Marshall R. Urist, who taught him the relevance of Bone Morphogenetic Proteins (BMPs) in bone research, and more particular, in including growth factors in bone biomaterials. In summer 1977 he was appointed as visiting professor at the University of Utah. In the 1980’s he started to cooperate with Chinese universities, which led to honorary appointments at several Chinese universities, among them the Beijing University and the University of Sichuan. Many Chinese students then received fellowships at the Amsterdam Free University, Leiden University, and Twente University. In 1994, the Chinese government awarded him with the Friendship Award, as an appreciation for his help to introduce biomaterials science into China and its universities. Under his supervision, about 50 students received their Ph.D. degrees, about half of them Dutch, and the other half from other European and Asian countries. He published about 350 scientific papers and holds several patents. His past scientific papers are still highly cited, as evidenced by his current (2015) Research Gate score of 45. His research concerned mainly implants to replace bone, bone joints, and teeth. Engineering technologies such as sintering and plasma spraying of calcium phosphate ceramics, introducing room temperature technologies to introduce BMPs and other drugs, including but not limited to antibiotics, into and onto bone implants, were designed and improved. He received many awards besides the already mentioned Chinese Friendship Award. To mention a few: the George Winter Award, the Clemson Award, Sir John Charnley Award, Honorary Member of the Dutch Society for Biomaterials. He was member, and elected as Fellow, of various professional societies such as The European Society for Biomaterials (ESB) and the American Society of Biomaterials, and was co-founder of the ESB. He (co-) founded a number of biomedical companies, such as CAM Bioceramics, which is a world leader in plasma sprayed calcium phosphate coatings and calcium phosphate particles repair and augmentation of skeletal implants; IsoTis as innovator in tissue engineering (Nasdaq listed for some time until it was incorporated into a US company); and Beijing Amsterdam Biomaterials (Beijing) which was set up to produce simple dental materials for the Chinese people (later sold to an internationally operating German dental company); and several others.